-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LG/XOrzpnqQYjGVN8OrDcmboLKV/Bx93nsCpk9U9JvNo/dVFYPFDk13RcSmwylJD KYGLDSt4ikKLaYqdP5fkOg== 0001140361-08-028374.txt : 20081219 0001140361-08-028374.hdr.sgml : 20081219 20081219163441 ACCESSION NUMBER: 0001140361-08-028374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081218 FILED AS OF DATE: 20081219 DATE AS OF CHANGE: 20081219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 BEAR TAVERN ROAD STREET 2: SUITE 201 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 850 BEAR TAVERN ROAD STREET 2: SUITE 201 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J CENTRAL INDEX KEY: 0001068029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 081261500 BUSINESS ADDRESS: STREET 1: C/O DISCOVERY LABORATORIES INC STREET 2: 3359 DURHAM ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 305-534-3383 MAIL ADDRESS: STREET 1: 1101 BRICKELL AVE STREET 2: #701 S CITY: MIAMI STATE: FL ZIP: 33131 FORMER NAME: FORMER CONFORMED NAME: SCHABER CHRISTOPHER DATE OF NAME CHANGE: 19980811 4 1 doc1.xml FORM 4 X0303 4 2008-12-18 0 0000812796 DOR BIOPHARMA INC DORB 0001068029 SCHABER CHRISTOPHER J 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 0.06 2008-12-18 4 A 0 2800000 0 A 2008-12-18 2018-12-17 Common Stock 2800000 2800000 D The stock options were granted at an exercise price of $0.06. The stock options, which are for a term of 10 years from the date of grant and subject to earlier termination upon the occurence of certain events related to termiatnion of employment, vest at a rate of 25% immediately and 25% per year for 3 years. /s/ Christopher J. Schaber 2008-12-19 -----END PRIVACY-ENHANCED MESSAGE-----